Dr. Zisman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2950 Cleveland Clinic Blvd
Bldg A
Weston, FL 33331Phone+1 818-825-5654Fax+1 805-898-3420
Summary
- Dr. David Zisman is a pulmonologist in Santa Barbara, CA and is affiliated with multiple hospitals in the area, including Santa Barbara Cottage Hospital and Ronald Reagan UCLA Medical Center. He received his medical degree from Central University of Venezuela and has been in practice 26 years. He also speaks multiple languages, including Spanish. He specializes in interstitial lung diseases, lung transplantation medicine, pleural disease, and restrictive lung disease and is experienced in pulmonary fibrosis, lung transplantation, interstitial lung disease, critical care medicine, and general pulmonology.
Education & Training
- UCLAMaster of Science, Clinical Research, 2004 - 2008
- University of MichiganFellowship, Pulmonary Disease and Critical Care Medicine, 1995 - 1998
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1992 - 1995
- Central University of VenezuelaClass of 1991
Certifications & Licensure
- FL State Medical License 2022 - 2026
- CA State Medical License 2003 - 2023
- PA State Medical License 2000 - 2004
- MI State Medical License 1995 - 1999
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Teacher of the Year Award Santa Barbara Cottage Hospital Residency Program, 2009
- Dyson Fellowship Research Award for Excellence in Clinical Research University of Pennsylvania Medical School, 2002
Clinical Trials
- Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension Start of enrollment: 2004 Nov 01
- Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis Start of enrollment: 2007 Aug 01
- Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan Start of enrollment: 2007 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 31 citationsScreening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study.Franck F Rahaghi, Nicholas A Kolaitis, Ayodeji Adegunsoye, Joao A de Andrade, Kevin R Flaherty
Chest. 2022-07-01 - 67 citationsUtility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease.Jamie S. Sheth, John A. Belperio, Michael C. Fishbein, Ella A. Kazerooni, Amir Lagstein
Chest. 2017-02-01 - 33 citationsThe Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): diagnostic and adjudication processes.Joao A. de Andrade, Marvin I. Schwarz, Harold R. Collard, Tedryl Gentry-Bumpass, Thomas V. Colby
Chest. 2015-10-01
Grant Support
- UCLA IPF Clinical Research NetworkNational Heart, Lung, And Blood Institute2005–2008
Professional Memberships
- Fellow
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: